Variant report
Variant | nsv966508 |
---|---|
Chromosome Location | chr4:18541086-18557079 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs553805045 | chr4:18541108-18541109 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs554832071 | chr4:18541113-18541114 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs80354583 | chr4:18541129-18541130 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs1382097 | chr4:18541134-18541135 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs552663719 | chr4:18541140-18541141 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs188027626 | chr4:18541148-18541149 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs6838041 | chr4:18541179-18541180 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
8 | rs191592003 | chr4:18541200-18541201 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs373562243 | chr4:18541202-18541203 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs547307696 | chr4:18541204-18541205 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs145898238 | chr4:18541210-18541211 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs542986524 | chr4:18541267-18541268 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs6816319 | chr4:18541314-18541315 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs138714761 | chr4:18541315-18541316 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs546993458 | chr4:18541394-18541395 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs370336672 | chr4:18541413-18541414 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs550674857 | chr4:18541426-18541427 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs565100617 | chr4:18541479-18541480 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs570595550 | chr4:18541480-18541481 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs532674274 | chr4:18541542-18541543 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs550777132 | chr4:18541547-18541548 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs142734381 | chr4:18541596-18541597 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs6816934 | chr4:18541631-18541632 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
24 | rs147352670 | chr4:18541635-18541636 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs573048467 | chr4:18541655-18541656 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs535396680 | chr4:18541683-18541684 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs555112664 | chr4:18541800-18541801 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs575073020 | chr4:18541811-18541812 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs544033245 | chr4:18541824-18541825 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs369849467 | chr4:18541830-18541831 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs147504404 | chr4:18541874-18541875 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs562742177 | chr4:18541930-18541931 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs368607148 | chr4:18541960-18541961 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs182999446 | chr4:18541984-18541985 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs564230031 | chr4:18542009-18542010 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs187989890 | chr4:18542043-18542044 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs1477899 | chr4:18542105-18542106 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs557083713 | chr4:18542170-18542171 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs575371428 | chr4:18542203-18542204 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs542847429 | chr4:18542228-18542229 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs540572205 | chr4:18542270-18542271 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs560294892 | chr4:18542271-18542272 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs141596262 | chr4:18542273-18542274 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs1477900 | chr4:18542289-18542290 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs565311430 | chr4:18542316-18542317 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs192257835 | chr4:18542322-18542323 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs550518240 | chr4:18542335-18542336 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs562643489 | chr4:18542360-18542361 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs367902595 | chr4:18542381-18542382 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs79436051 | chr4:18542382-18542383 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Oral squamous cell carcinoma | 17134496 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17603634 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 17533364 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Cancer | 21637783 | CNVD |
Melanoma | 21693616 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Cervical cancer | 21062161 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Neuroblastoma | 18923191 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Breast cancer | 17133270 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 22183965 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 17908972 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:18538600-18541400 | Weak transcription | HUVEC | blood vessel |
2 | chr4:18541400-18543200 | Enhancers | HUVEC | blood vessel |
3 | chr4:18543400-18544000 | Enhancers | Pancreatic Islets | Pancreatic Islet |
4 | chr4:18555800-18558800 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
5 | chr4:18556800-18558600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
6 | chr4:18557000-18558600 | Enhancers | HUES64 Cell Line | embryonic stem cell |